Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date of authorisation: 25/10/2005, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date of authorisation: 25/10/2005, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date of authorisation: 25/10/2005, Revision: 46, Status: Authorised

Media briefing on global health issues 19 July 2023

Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief